ArticleJournal of veterinary pharmacology and therapeutics2022

Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1-deficient collie dogs.

Marlene Drag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.